Protein-Serine-Threonine Kinases (chemistry) < Protein-Serine-Threonine Kinases (genetics) < Protein-Serine-Threonine Kinases (metabolism)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 101.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000571 (2001)	C. Klein ; G S Stewart ; N P Quinn ; A M Taylor	Ataxia without telangiectasia revisited: update on genetic findings in two brothers with an ataxia-telangiectasia-like disorder.
001263 (2005)	Aideen Mcinerney-Leo	Genetic testing in Parkinson's disease.
001311 (2005)	Denise M. Kay ; Patricia Kramer ; Don Higgins ; Cyrus P. Zabetian ; Haydeh Payami	Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.
001428 (2005)	Jose Miguel Bras [Portugal] ; Rita Joao Guerreiro ; Maria Helena Ribeiro ; Cristina Januario ; Ana Morgadinho ; Catarina Resende Oliveira ; Luis Cunha ; John Hardy ; Andrew Singleton	G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort.
001516 (2006)	Denise M. Kay [États-Unis] ; Cyrus P. Zabetian ; Stewart A. Factor ; John G. Nutt ; Ali Samii ; Alida Griffith ; Tom D. Bird ; Patricia Kramer ; Donald S. Higgins ; Haydeh Payami	Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.
001581 (2006)	Hon-Chung Fung [États-Unis] ; Chiung-Mei Chen ; John Hardy ; Dena Hernandez ; Andrew Singleton ; Yih-Ru Wu	Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease.
001634 (2006)	E K Tan [Singapour] ; Lisa Skipper ; Eva Chua ; Meng-Cheong Wong ; Ratnagopal Pavanni ; Carine Bonnard ; Prasanna Kolatkar ; Jian-Jun Liu	Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease.
001642 (2006)	Hiroyuki Tomiyama [Japon] ; Yuanzhe Li ; Manabu Funayama ; Kazuko Hasegawa ; Hiroyo Yoshino ; Shin-Ichiro Kubo ; Kenichi Sato ; Tatsuya Hattori ; Chin-Song Lu ; Rivka Inzelberg ; Ruth Djaldetti ; Eldad Melamed ; Rim Amouri ; Neziha Gouider-Khouja ; Faycal Hentati ; Yasuko Hatano ; Mei Wang ; Yoko Imamichi ; Koichi Mizoguchi ; Hiroaki Miyajima ; Fumiya Obata ; Tatsushi Toda ; Matthew J. Farrer ; Yoshikuni Mizuno ; Nobutaka Hattori	Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries.
001646 (2006)	Roberta Marongiu [Italie] ; Daniele Ghezzi ; Tamara Ialongo ; Francesco Soleti ; Antonio Elia ; Stefania Cavone ; Alberto Albanese ; Maria Concetta Altavista ; Paolo Barone ; Livia Brusa ; Pietro Cortelli ; Lucia Petrozzi ; Cesa Scaglione ; Paolo Stanzione ; Michele Tinazzi ; Massimo Zeviani ; Bruno Dallapiccola ; Anna Rita Bentivoglio ; Enza Maria Valente ; Barbara Garavaglia	Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.
001666 (2006)	Ioannis U. Isaias [Italie] ; Riccardo Benti ; Stefano Goldwurm ; Michela Zini ; Roberto Cilia ; Paolo Gerundini ; Alessio Di Fonzo ; Vincenzo Bonifati ; Gianni Pezzoli ; Angelo Antonini	Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation.
001726 (2006)	Katja Hedrich [Allemagne] ; Susen Winkler ; Johann Hagenah ; Kemal Kabakci ; Meike Kasten ; Eberhard Schwinger ; Jens Volkmann ; Peter P. Pramstaller ; Vladimir Kostic ; Peter Vieregge ; Christine Klein	Recurrent LRRK2 (Park8) mutations in early-onset Parkinson's disease.
001765 (2006)	Andrea Carmine Belin [Suède] ; Marie Westerlund ; Olof Sydow ; Karin Lundströmer ; Anna H Kansson ; Hans Nissbrandt ; Lars Olson ; Dagmar Galter	Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.
001855 (2006)	Javier Sim N-Sánchez [Espagne] ; José-Félix Martí-Mass ; José Vicente Sánchez-Mut ; Coro Paisán-Ruiz ; Angel Martínez-Gil ; Javier Ruiz-Martínez ; Amets Sáenz ; Andrew B. Singleton ; Adolfo L Pez De Munain ; Jordi Pérez-Tur	Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques.
001899 (2006)	Sofya N. Pchelina [Russie] ; Andrei F. Yakimovskii ; Olga N. Ivanova ; Anton K. Emelianov ; Andrei H. Zakharchuk ; Alexander L. Schwarzman	G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia.
001913 (2006)	Nathan Pankratz [États-Unis] ; Michael W. Pauciulo ; Veronika E. Elsaesser ; Diane K. Marek ; Cheryl A. Halter ; Alice Rudolph ; Clifford W. Shults ; Tatiana Foroud ; William C. Nichols	Mutations in LRRK2 other than G2019S are rare in a north American-based sample of familial Parkinson's disease.
001921 (2007)	Michael Schüpbach [France] ; Ebba Lohmann ; Mathieu Anheim ; Suzanne Lesage ; Virginie Czernecki ; Sadek Yaici ; Yulia Worbe ; Perrine Charles ; Marie-Laure Welter ; Pierre Pollak ; Alexandra Dürr ; Yves Agid [France] ; Alexis Brice	Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
001933 (2007)	Eng-King Tan [Singapour] ; Lisa Skipper ; Louis Tan ; Jian-Jun Liu	LRRK2 G2019S founder haplotype in the Chinese population.
001941 (2007)	David Gosal ; Timothy Lynch ; Owen A. Ross ; Kristoffer Haugarvoll ; Matthew J. Farrer ; J Mark Gibson	Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred.
001960 (2007)	Lianna Ishihara [Royaume-Uni] ; Rachel A. Gibson ; Liling Warren ; Rim Amouri ; Kelly Lyons ; Catherine Wielinski ; Christine Hunter ; Jina E. Swartz ; Ramu Elango ; P Anthony Akkari ; David Leppert ; Linda Surh ; Kevin H. Reeves ; Siwan Thomas ; Leigh Ragone ; Nobutaka Hattori ; Rajesh Pahwa ; Joseph Jankovic [États-Unis] ; Martha Nance ; Alan Freeman ; Neziha Gouider-Khouja ; Mounir Kefi ; Mourad Zouari ; Samia Ben Sassi ; Samia Ben Yahmed ; Ghada El Euch-Fayeche ; Lefkos Middleton ; David J. Burn ; Ray L. Watts ; Faycal Hentati	Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families.
001993 (2007)	William C. Nichols [États-Unis] ; Diane K. Marek ; Michael W. Pauciulo ; Nathan Pankratz ; Cheryl A. Halter ; Alice Rudolph ; Clifford W. Shults ; Joanne Wojcieszek ; Tatiana Foroud	R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation.
001A03 (2007)	Maria Teresa Giordana [Italie] ; Carla D'Agostino ; Giovanni Albani ; Alessandro Mauro ; Alessio Di Fonzo ; Angelo Antonini ; Vincenzo Bonifati	Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Protein-Serine-Threonine Kinases (genetics)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Protein-Serine-Threonine Kinases (genetics)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Protein-Serine-Threonine Kinases (genetics)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024